Paul Tudor Jones Lucira Health, Inc. Transaction History

Tudor Investment Corp Et Al

  • $19.2 Billion
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
BUY
$2.86 - $8.83 $43,966 - $135,743
15,373 Added 98.36%
31,002 $111,000
Q4 2021

Feb 14, 2022
BUY
$4.94 - $8.94 $77,207 - $139,723
15,629 New
15,629 $135,000

Others Institutions Holding LHDX

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About Lucira Health, Inc.

LHDX Quotes by TradingView
  • Ticker LHDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 40,106,500
  • Market Cap $1.2M
  • Description
  • Lucira Health, Inc., a medical technology company, focuses on the development and commercialization of infectious disease test kits. It develops a testing platform that produces molecular testing services. The company offers LUCIRA COVID-19 All-In-One Test Kit, a COVID-19 test kit; and develops influenza A and B viruses test kits. It has a paten...
More about LHDX
Track Paul Tudor Jones's Portfolio

Track Paul Tudor Jones Portfolio

Follow Paul Tudor Jones (Tudor Investment Corp Et Al) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email